866-997-4948(US-Canada Toll Free)

United States Muscle Relaxant Drugs Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 100 Pages

In this report, the United States Muscle Relaxant Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Muscle Relaxant Drugs in these regions, from 2012 to 2022 (forecast).

United States Muscle Relaxant Drugs market competition by top manufacturers/players, with Muscle Relaxant Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Abbott Laboratories
Mallinckrodt
Medtronic Neuromodulation (Medtronic)
Vertical Pharmaceuticals LLC
Johnson & Johnson
Par Sterile Products
Endo Pharmaceuticals
SteriMax Inc
Upsher Smith Laboratories
Orient Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Facial Aesthetic Relaxants
Centrally Acting Muscle Relaxants
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Muscle Relaxant Drugs for each application, including
Hospitals
Clinics
Other

Table of Contents

United States Muscle Relaxant Drugs Market Report 2017
1 Muscle Relaxant Drugs Overview
1.1 Product Overview and Scope of Muscle Relaxant Drugs
1.2 Classification of Muscle Relaxant Drugs by Product Category
1.2.1 United States Muscle Relaxant Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Muscle Relaxant Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Facial Aesthetic Relaxants
1.2.4 Centrally Acting Muscle Relaxants
1.2.5 Other
1.3 United States Muscle Relaxant Drugs Market by Application/End Users
1.3.1 United States Muscle Relaxant Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 United States Muscle Relaxant Drugs Market by Region
1.4.1 United States Muscle Relaxant Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Muscle Relaxant Drugs Status and Prospect (2012-2022)
1.4.3 Southwest Muscle Relaxant Drugs Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Muscle Relaxant Drugs Status and Prospect (2012-2022)
1.4.5 New England Muscle Relaxant Drugs Status and Prospect (2012-2022)
1.4.6 The South Muscle Relaxant Drugs Status and Prospect (2012-2022)
1.4.7 The Midwest Muscle Relaxant Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Muscle Relaxant Drugs (2012-2022)
1.5.1 United States Muscle Relaxant Drugs Sales and Growth Rate (2012-2022)
1.5.2 United States Muscle Relaxant Drugs Revenue and Growth Rate (2012-2022)

2 United States Muscle Relaxant Drugs Market Competition by Players/Suppliers
2.1 United States Muscle Relaxant Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Muscle Relaxant Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Muscle Relaxant Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Muscle Relaxant Drugs Market Competitive Situation and Trends
2.4.1 United States Muscle Relaxant Drugs Market Concentration Rate
2.4.2 United States Muscle Relaxant Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Muscle Relaxant Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Muscle Relaxant Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Muscle Relaxant Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Muscle Relaxant Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Muscle Relaxant Drugs Price by Region (2012-2017)

4 United States Muscle Relaxant Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Muscle Relaxant Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Muscle Relaxant Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Muscle Relaxant Drugs Price by Type (2012-2017)
4.4 United States Muscle Relaxant Drugs Sales Growth Rate by Type (2012-2017)

5 United States Muscle Relaxant Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Muscle Relaxant Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Muscle Relaxant Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Muscle Relaxant Drugs Players/Suppliers Profiles and Sales Data
6.1 Abbott Laboratories
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Muscle Relaxant Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Abbott Laboratories Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Mallinckrodt
6.2.2 Muscle Relaxant Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Mallinckrodt Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Medtronic Neuromodulation (Medtronic)
6.3.2 Muscle Relaxant Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Medtronic Neuromodulation (Medtronic) Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Vertical Pharmaceuticals LLC
6.4.2 Muscle Relaxant Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Vertical Pharmaceuticals LLC Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Johnson & Johnson
6.5.2 Muscle Relaxant Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Johnson & Johnson Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Par Sterile Products
6.6.2 Muscle Relaxant Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Par Sterile Products Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Endo Pharmaceuticals
6.7.2 Muscle Relaxant Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Endo Pharmaceuticals Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 SteriMax Inc
6.8.2 Muscle Relaxant Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 SteriMax Inc Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Upsher Smith Laboratories
6.9.2 Muscle Relaxant Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Upsher Smith Laboratories Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Orient Pharma
6.10.2 Muscle Relaxant Drugs Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Orient Pharma Muscle Relaxant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Muscle Relaxant Drugs Manufacturing Cost Analysis
7.1 Muscle Relaxant Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Muscle Relaxant Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Muscle Relaxant Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Muscle Relaxant Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Muscle Relaxant Drugs Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Muscle Relaxant Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Muscle Relaxant Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Muscle Relaxant Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Muscle Relaxant Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Muscle Relaxant Drugs
Figure United States Muscle Relaxant Drugs Market Size (MT) by Type (2012-2022)
Figure United States Muscle Relaxant Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Facial Aesthetic Relaxants Product Picture
Figure Centrally Acting Muscle Relaxants Product Picture
Figure Other Product Picture
Figure United States Muscle Relaxant Drugs Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Muscle Relaxant Drugs by Application in 2016
Figure Hospitals Examples
Figure Clinics Examples
Figure Other Examples
Figure United States Muscle Relaxant Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Muscle Relaxant Drugs Sales (MT) and Growth Rate (2012-2022)
Figure United States Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Muscle Relaxant Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Muscle Relaxant Drugs Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Muscle Relaxant Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Muscle Relaxant Drugs Sales Share by Players/Suppliers
Figure 2017 United States Muscle Relaxant Drugs Sales Share by Players/Suppliers
Figure United States Muscle Relaxant Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Muscle Relaxant Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Muscle Relaxant Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Muscle Relaxant Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Muscle Relaxant Drugs Revenue Share by Players/Suppliers
Table United States Market Muscle Relaxant Drugs Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Muscle Relaxant Drugs Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Muscle Relaxant Drugs Market Share of Top 3 Players/Suppliers
Figure United States Muscle Relaxant Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Muscle Relaxant Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Muscle Relaxant Drugs Product Category
Table United States Muscle Relaxant Drugs Sales (MT) by Region (2012-2017)
Table United States Muscle Relaxant Drugs Sales Share by Region (2012-2017)
Figure United States Muscle Relaxant Drugs Sales Share by Region (2012-2017)
Figure United States Muscle Relaxant Drugs Sales Market Share by Region in 2016
Table United States Muscle Relaxant Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Muscle Relaxant Drugs Revenue Share by Region (2012-2017)
Figure United States Muscle Relaxant Drugs Revenue Market Share by Region (2012-2017)
Figure United States Muscle Relaxant Drugs Revenue Market Share by Region in 2016
Table United States Muscle Relaxant Drugs Price (USD/MT) by Region (2012-2017)
Table United States Muscle Relaxant Drugs Sales (MT) by Type (2012-2017)
Table United States Muscle Relaxant Drugs Sales Share by Type (2012-2017)
Figure United States Muscle Relaxant Drugs Sales Share by Type (2012-2017)
Figure United States Muscle Relaxant Drugs Sales Market Share by Type in 2016
Table United States Muscle Relaxant Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Muscle Relaxant Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Muscle Relaxant Drugs by Type (2012-2017)
Figure Revenue Market Share of Muscle Relaxant Drugs by Type in 2016
Table United States Muscle Relaxant Drugs Price (USD/MT) by Types (2012-2017)
Figure United States Muscle Relaxant Drugs Sales Growth Rate by Type (2012-2017)
Table United States Muscle Relaxant Drugs Sales (MT) by Application (2012-2017)
Table United States Muscle Relaxant Drugs Sales Market Share by Application (2012-2017)
Figure United States Muscle Relaxant Drugs Sales Market Share by Application (2012-2017)
Figure United States Muscle Relaxant Drugs Sales Market Share by Application in 2016
Table United States Muscle Relaxant Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Muscle Relaxant Drugs Sales Growth Rate by Application (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Muscle Relaxant Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Abbott Laboratories Muscle Relaxant Drugs Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Muscle Relaxant Drugs Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Muscle Relaxant Drugs Revenue Market Share in United States (2012-2017)
Table Mallinckrodt Basic Information List
Table Mallinckrodt Muscle Relaxant Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mallinckrodt Muscle Relaxant Drugs Sales Growth Rate (2012-2017)
Figure Mallinckrodt Muscle Relaxant Drugs Sales Market Share in United States (2012-2017)
Figure Mallinckrodt Muscle Relaxant Drugs Revenue Market Share in United States (2012-2017)
Table Medtronic Neuromodulation (Medtronic) Basic Information List
Table Medtronic Neuromodulation (Medtronic) Muscle Relaxant Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Medtronic Neuromodulation (Medtronic) Muscle Relaxant Drugs Sales Growth Rate (2012-2017)
Figure Medtronic Neuromodulation (Medtronic) Muscle Relaxant Drugs Sales Market Share in United States (2012-2017)
Figure Medtronic Neuromodulation (Medtronic) Muscle Relaxant Drugs Revenue Market Share in United States (2012-2017)
Table Vertical Pharmaceuticals LLC Basic Information List
Table Vertical Pharmaceuticals LLC Muscle Relaxant Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Vertical Pharmaceuticals LLC Muscle Relaxant Drugs Sales Growth Rate (2012-2017)
Figure Vertical Pharmaceuticals LLC Muscle Relaxant Drugs Sales Market Share in United States (2012-2017)
Figure Vertical Pharmaceuticals LLC Muscle Relaxant Drugs Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Muscle Relaxant Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Muscle Relaxant Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Muscle Relaxant Drugs Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Muscle Relaxant Drugs Revenue Market Share in United States (2012-2017)
Table Par Sterile Products Basic Information List
Table Par Sterile Products Muscle Relaxant Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Par Sterile Products Muscle Relaxant Drugs Sales Growth Rate (2012-2017)
Figure Par Sterile Products Muscle Relaxant Drugs Sales Market Share in United States (2012-2017)
Figure Par Sterile Products Muscle Relaxant Drugs Revenue Market Share in United States (2012-2017)
Table Endo Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Muscle Relaxant Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Endo Pharmaceuticals Muscle Relaxant Drugs Sales Growth Rate (2012-2017)
Figure Endo Pharmaceuticals Muscle Relaxant Drugs Sales Market Share in United States (2012-2017)
Figure Endo Pharmaceuticals Muscle Relaxant Drugs Revenue Market Share in United States (2012-2017)
Table SteriMax Inc Basic Information List
Table SteriMax Inc Muscle Relaxant Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure SteriMax Inc Muscle Relaxant Drugs Sales Growth Rate (2012-2017)
Figure SteriMax Inc Muscle Relaxant Drugs Sales Market Share in United States (2012-2017)
Figure SteriMax Inc Muscle Relaxant Drugs Revenue Market Share in United States (2012-2017)
Table Upsher Smith Laboratories Basic Information List
Table Upsher Smith Laboratories Muscle Relaxant Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Upsher Smith Laboratories Muscle Relaxant Drugs Sales Growth Rate (2012-2017)
Figure Upsher Smith Laboratories Muscle Relaxant Drugs Sales Market Share in United States (2012-2017)
Figure Upsher Smith Laboratories Muscle Relaxant Drugs Revenue Market Share in United States (2012-2017)
Table Orient Pharma Basic Information List
Table Orient Pharma Muscle Relaxant Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Orient Pharma Muscle Relaxant Drugs Sales Growth Rate (2012-2017)
Figure Orient Pharma Muscle Relaxant Drugs Sales Market Share in United States (2012-2017)
Figure Orient Pharma Muscle Relaxant Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Muscle Relaxant Drugs
Figure Manufacturing Process Analysis of Muscle Relaxant Drugs
Figure Muscle Relaxant Drugs Industrial Chain Analysis
Table Raw Materials Sources of Muscle Relaxant Drugs Major Players/Suppliers in 2016
Table Major Buyers of Muscle Relaxant Drugs
Table Distributors/Traders List
Figure United States Muscle Relaxant Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Muscle Relaxant Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Muscle Relaxant Drugs Price (USD/MT) Trend Forecast (2017-2022)
Table United States Muscle Relaxant Drugs Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Muscle Relaxant Drugs Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Muscle Relaxant Drugs Sales Volume (MT) Forecast by Type in 2022
Table United States Muscle Relaxant Drugs Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Muscle Relaxant Drugs Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Muscle Relaxant Drugs Sales Volume (MT) Forecast by Application in 2022
Table United States Muscle Relaxant Drugs Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Muscle Relaxant Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Muscle Relaxant Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Muscle Relaxant Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *